Response of brain metastases from breast cancer to systemic chemotherapy.
about
Breast cancer brain metastases: the last frontierManagement of solitary and multiple brain metastases from breast cancerPerillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesTemozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.Current management of metastatic brain diseaseCarmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.A review of current management of brain metastases.Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrierPhase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.Treatment of Breast Cancer Brain Metastases.A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive management.Innovative therapeutic strategies in the treatment of brain metastases.Chemotherapy and targeted molecular therapies for brain metastases.Breast cancer brain metastases: new directions in systemic therapyClinical management of brain metastasis.Trastuzumab in the management of early and advanced stage breast cancer.Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline.Brain metastases: a medical neuro-oncology perspective.Brain metastases as preventive and therapeutic targets.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Treatment of brain metastases: chemotherapy.Chemotherapy as primary treatment for brain metastases from breast cancer: analysis of 115 one-year survivors.Optimal management of brain metastases from breast cancer. Issues and considerations.Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts.Brain metastasis: new opportunities to tackle therapeutic resistance.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Systemic therapy of brain metastases.Control of the blood-brain barrier function in cancer cell metastasis.Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.The treatment of brain metastases.Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.
P2860
Q26775663-6698BA34-41B7-49F6-85F8-10FF9102B91AQ26865562-D79EA459-DB79-4D8D-8EB7-C6B5051BF9D9Q28072442-18E458A5-82F4-46F4-8E87-143C326835E5Q33370672-FDBB5E2B-9BEB-458B-94A8-A44A039C2BFBQ33387996-82FD9BA7-A5E6-4DEB-922B-C00E77C0F531Q33475484-CFE2D6DA-B1D5-4632-9F44-8BBED8AB9E66Q33595274-0F6E6DD9-1BA5-40F9-AA4A-ED4DB61C702DQ33909294-DD7F323D-CCBA-47EA-B315-F0447425FF52Q34000987-D9F43129-8AF5-4EFB-B9BF-927E8B49A9D2Q34393640-677C14D7-7BBA-4E35-8E1C-7F11B21B1FACQ34872345-0250EA8D-6329-4A0E-8C37-20895063BCA8Q35030625-51D85658-B303-4DD4-AA9B-AB8A86B26700Q35914677-1F24B44B-C3C2-4E0D-827F-9538CF568367Q36057858-F2B4233E-6AF2-49DE-8612-336BEA034589Q36116016-EA9EB3B4-830D-4AF2-9655-11294B764B77Q36229756-D7E8A25F-7237-4D6A-B91C-CD5B1883449AQ36590195-89089FD0-EB1E-4E63-BBE5-7404EABF6BC3Q36641504-F2D754BB-AAAD-4A0B-9047-8F22263E1B81Q36822500-7A92B7F7-7AA8-424A-8BF1-543945D100EBQ36896269-DC4594E4-48AB-4CC8-A677-443D2720BAEAQ37290613-D605E102-13F6-4635-A063-52F96F01C386Q37698300-B4CACB74-E3DA-4F0C-848A-D09B303DC031Q37724219-85954E82-019E-47A2-8BA8-8AFB5ADEE271Q37862581-C3CEA746-0E82-42BD-B9D9-B6E7BF31AE36Q37870216-871A8F97-A2D5-46B4-8AF3-E21A1097289AQ37967507-EB44F5DF-E599-44E6-9CEE-5927CD5E7F36Q38004782-E6BC1C63-7FCF-4B8D-A8B5-5E87626DC323Q38067340-083BB6DF-ECFC-4878-A1F2-3F25BC589370Q38155202-AF34AE76-BAB7-4BC8-977A-0985CC5F1D78Q38222247-9F873055-29A0-4C37-A900-3BE9C469A868Q38230553-CC9C06E9-E3B8-4DF8-AE45-3C94A48BA535Q38285931-D10469CC-1ACD-4AD6-8E0D-85A8213A691EQ38511670-844B7E63-83A1-4C96-8DC0-96D0FD62E950Q38688750-FEBAA856-E93B-44B6-9048-DE983FB1B31BQ39775271-89198154-83CC-4B05-B60A-CB88E22EFBDAQ40968171-36DEE18B-BB38-4202-992E-D922A1A987BFQ43589739-9B36A9B8-9C65-43BC-98DB-2CD68440A11EQ44417765-796F4CD0-9647-457A-86DE-6601B01965A6Q44625585-57F1CA6B-6390-4FF8-A29D-951A9FDB85C2Q47549277-25C74849-16A3-487F-8B3B-6B4897823955
P2860
Response of brain metastases from breast cancer to systemic chemotherapy.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Response of brain metastases from breast cancer to systemic chemotherapy.
@en
type
label
Response of brain metastases from breast cancer to systemic chemotherapy.
@en
prefLabel
Response of brain metastases from breast cancer to systemic chemotherapy.
@en
P2093
P1433
P1476
Response of brain metastases from breast cancer to systemic chemotherapy.
@en
P2093
van der Sande JJ
P2860
P304
P356
10.1002/1097-0142(19920215)69:4<972::AID-CNCR2820690423>3.0.CO;2-P
P407
P577
1992-02-01T00:00:00Z